Steps forward in minimally invasive cardiac surgery: 10-year experience

Publication date: Available online 21 June 2019Source: The Annals of Thoracic SurgeryAuthor(s): Cristina Barbero, Giovanni Marchetto, Davide Ricci, Erik Cura Stura, Alberto Clerici, Suad El Qarra, Claudia Filippini, Massimo Boffini, Mauro RinaldiAbstractBackgroundMinimally invasive cardiac surgery (MICS) has constantly evolved over the past years and new technologies have been introduced. Aims of this study are to analyze the evolution of our 10-year experience in MICS and to highlight outcomes in different spans of time.MethodsPatients undergoing MICS for mitral valve and/or tricuspid valve and/or atrial septal defect or atrial masses from November 2005 to November 2015 were retrospectively analyzed. A comparative analysis was performed by identifying 2 groups: the control group (in the first time span of our experience) and the tailored group (patients that underwent surgery after a full preoperative anatomical evaluation with allocation to the proper setting).ResultsDuring the study period 971 patients underwent MICS. MICS procedures increase from 44% in 2006 to 96% in 2015. Subgroup analysis revealed a significant decrease in the rate of procedures performed with retrograde arterial perfusion (99.1% versus 91.7%, p
Source: The Annals of Thoracic Surgery - Category: Cardiovascular & Thoracic Surgery Source Type: research

Related Links:

CONCLUSIONS: MIS closure for ASD has similar outcomes compared to TC repair. However, the lack of randomised literature related to MIS versus TC repair for ASD closure warrants further evidence in the form of RCTs to further support these findings.PMID:34109866 | DOI:10.1177/02676591211021935
Source: Perfusion - Category: Cardiovascular & Thoracic Surgery Authors: Source Type: research
ConclusionsWe demonstrate the first successful use of an SCPD during surgical excision of a mal-deployed occluder. With its ease of use and safety, SCPD may have utility in surgeries with high cardio-embolic risk.
Source: Journal of Cardiac Surgery - Category: Cardiovascular & Thoracic Surgery Authors: Tags: CASE REPORT Source Type: research
Ebstein’s anomaly and pregnancy Ebstein’s anomaly of tricuspid valve was first described by Wilhelm Ebstein in 1866 [1]. It is characterized by distal displacement of the septal and posterior leaflets of tricuspid valve. Anterior leaflet is elongated and sail like. A portion of the right ventricle is ‘atrialized’ due to the distal displacement of the tricuspid valve. Right atrium is often grossly dilated. Right to left shunting occurs across a patent foramen ovale producing cyanosis of variable extent. Ebstein’s anomaly is one of the cyanotic congenital heart diseases in which survival to adul...
Source: Cardiophile MD - Category: Cardiology Authors: Tags: Cardiology Source Type: blogs
This study investigated unknown risk factors for the development of new-onset ATA after transcatheter ASD closure in patients without a history of ATA.
Source: Heart, Lung and Circulation - Category: Cardiology Authors: Tags: Original Article Source Type: research
ASD device closure has become a de-facto modality for most ostium secundum defects(25/year) shall prevail over surgery in most patients with ASD.  Reference 1López-Fernández T1, Gómez de Diego JJ, Monedero MC . Aortic wall erosion after percutaneous closure of atrial septal defect.Am Soc Echocardiogr. 2011 Feb;24(2):227.e5-8     2.Amin Z Echocardiographic predictors of cardiac erosion after Amplatzer septal occluder placement.atheter Cardiovasc Interv. 2014 Jan 1;83(1):84-92.    3.Catheter Cardiovasc Interv. 2012 Aug 1;80(Percutaneous atrial septal oc...
Source: Dr.S.Venkatesan MD - Category: Cardiology Authors: Tags: Uncategorized asd device closure and aortic erosion atrial septal defect closure by amplatzer ias dynamics late migration of asd device mechanism of of aortic erosion surgery vs device asd closure transverse sinus pericardium effuion ias asd Source Type: blogs
ConclusionsRight mini ‐thoracotomy cardiac surgery in selected patients with GUCH allows to avoid the big scar of the sternotomy approach and to accelerate the recovery in a young population. Moreover, in redo cases, it allows the surgeon to reach the heart and the aorta avoiding the well‐known risks of a re‐sterno tomy procedure.
Source: Journal of Cardiac Surgery - Category: Cardiovascular & Thoracic Surgery Authors: Tags: ORIGINAL ARTICLE Source Type: research
Kardiol Pol. 2021 Feb 17. doi: 10.33963/KP.15817. Online ahead of print.ABSTRACTPatent foramen ovale is a congenital heart disease, which represents 80% of atrial septal defects and consist of a remnant of fetal circulation that functions in post-natal conditions as a transient interatrial right-to-left shunt of variable magnitude. The PFO may be implicated in the pathogenesis of several medical conditions, such as cryptogenic stroke, cryptogenic left circulation thromboembolism, migraine syndromes, decompression sickness. The most frequent indication for PFO closure remains PFO-associated left circulation thromboembolism....
Source: Kardiologia Polska - Category: Cardiology Authors: Source Type: research
Abstract Patent foramen ovale is a congenital heart disease, which represents 80% of atrial septal defects and consist of a remnant of fetal circulation that functions in post-natal conditions as a transient interatrial right-to-left shunt of variable magnitude. The PFO may be implicated in the pathogenesis of several medical conditions, such as cryptogenic stroke, cryptogenic left circulation thromboembolism, migraine syndromes, decompression sickness. The most frequent indication for PFO closure remains PFO-associated left circulation thromboembolism. In select patients, PFO closure reduces stroke recurrence in ...
Source: Polish Heart Journal - Category: Cardiology Authors: Tags: Kardiol Pol Source Type: research
AbstractFew studies have reported the efficacy of Occlutech Figulla Flex II (FFII) device compared with Amplatzer Septal Occluder (ASO) device. The aim of this study was to examine the efficacy and safety of FFII compared with ASO for transcatheter atrial septal defect (ASD) closure. We retrospectively evaluated 190 patients using FFII and 190 patients using ASO who underwent transcatheter ASD closure. ASD characteristics were evaluated by transesophageal echocardiography. The prevalence of procedural complications, including erosion, device embolization, stroke, and new-onset atrial arrhythmia, and the presence of a resid...
Source: Heart and Vessels - Category: Cardiology Source Type: research
CONCLUSION: On a detailed literature search, this largest LAAO experience in structural heart diseases indicates its utility. OAC for six months followed by aspirin seems to prevent thrombus formation in these patients. The only incidence of early thrombus formation indicates immunity from clot formation after device endothelialisation. Larger multicenter trials combining LAAO with structural interventions in valvular AF are warranted in developing nations.PMID:33189196 | PMC:PMC7670275 | DOI:10.1016/j.ihj.2020.07.019
Source: Indian Heart J - Category: Cardiology Authors: Source Type: research
More News: Atrial Septal Defect | Brain | Cardiovascular & Thoracic Surgery | Hole in the Heart | Neurology | Neurosurgery | Perfusion | Stroke | Study